Connect with us

Government

Goldman Sachs: These 3 Stocks Could Spike at Least 40%

Let’s talk volatility. The NASDAQ kicked off this week with a dip into correction territory, a fall to just over 10% below its February peak. And now? After three trading
Read More…
The post Goldman Sachs: These 3 Stocks Could Spike at Least 40% appeare

Published

on

Let’s talk volatility. The NASDAQ kicked off this week with a dip into correction territory, a fall to just over 10% below its February peak. And now? After three trading sessions, the index has bounced back by 5.5%.

Behind the volatility lies an economy that may be gearing up to blast off. The strategy team at Goldman Sachs sees the February jobs numbers, along with the COVID relief package in Congress (the House has just passed the Senate version, sending the bill to President Biden’s desk), as net positives. Goldman economist Jan Hatzius predicts a 7.7% GDP for 2021, and says of immediate conditions, “The main reason that we expect a hiring boom this year is that reopening, fiscal stimulus, and pent-up savings should fuel very strong demand growth.”

Following up on Hatzius’ optimism, Goldman’s stock analysts have been busy tapping the stocks they see as potential winners under current conditions. They have certain commonalities that would increase their interest for investors: Strong Buy ratings, and, according to Goldman, at least 40% upside potential for the next 12 months. Let’s find out what else makes these particular stock so compelling.

Bioventus (BVS)

The first Goldman pick we’re looking at is Bioventus, a medical innovator. The company has an active development program focused on treatments to enhance the body’s natural healing abilities. The company’s goal is to promote healing through minimally invasive treatments that are clinically effective and cost efficient. The company’s product line is focused on the skeletal system, with products to enhance bone healing, joint therapies, and bone graft surgical procedures. Bioventus has a presence in 30 countries around the world.

In February of this year, Bioventus held its IPO, setting the initial price of the shares in the $16 to $18 range. When shares started trading on the NASDAQ on February 11, the opening price was $13, below the range. The company put 8 million shares on the market that day, and they closed at a price of $18.43. The sale grossed $153 million, with net proceeds of $104 million for Bioventus.

The next big data point for investors will come on March 25, when Bioventus releases its 4Q20 and full year results. While these numbers will cover a period before the company’s IPO, the first quarterly report as a public company is always eagerly watched.

Bioventus shares have slipped since they started trading – the stock is down 29% in its first month on the market. Goldman Sachs, however, thinks this new, lower stock price could offer new investors an opportunity to get into BVS on the cheap.

In his note for Goldman, analyst Amit Hazan writes, “[We] see recent stock underperformance offering a solid entry point into a story that includes a notable portfolio of joint preservation opportunities, and broad M&A opportunities that should offer a high likelihood of upside to numbers in the years ahead.”

The analyst added, “Key growth drivers include: a strong portfolio across the better growing segment of the HA market; market share opportunities in the bone graft market; a large direct sales force presence and network of independent distributors that can be leveraged as new products are introduced…”

To this end, Hazan rates BVS a Buy and his $19 price target suggests a 42% one-year upside potential. (To watch Hazan’s track record, click here)

Wall Street’s analysts clearly like BVS shares, as the 4 recent reviews are all Buys, making the Strong Buy consensus rating unanimous. The shares are currently priced at $13.33, and the $19.25 average price target implies an upside of 44% for the year ahead. (See BVS stock analysis on TipRanks)

Salesforce.com (CRM)

Next up, Salesforce, is one of the market’s biggest names in tech and marketing. The company is a leader in Customer Relationship Management (CRM), even taking its ticker from its leading products. Salesforce offers its customers cloud-based SaaS solutions for most of the front-end issues marketing departments cope with on a daily basis.

Salesforce shares have gained 40% in the past 12 months, as the company’s products and business model have proven easily adaptable to the pandemic-driven move toward remote offices and virtual commuting. After flat revenues in 1Q20, the company showed top-line gains in each of the next three quarters, as well as year-over-year gains.

In Q4, the most recent reported, the company beat the forecasts by wide margins. Top line revenue came in at $5.82 billion, above the $5.68 billion expected and up 20% year-over-year. EPS, at 28 cents, was a strong turnaround from the 28-cent loss recorded in 4Q19.

Also in the fourth quarter, Salesforce continued in its moves to acquire and integrate the communications app Slack. The acquisition is worth $27.7 billion, and is expected to close by July 31 of this year.

Covering Salesforce for Goldman is 5-star analyst Kash Rangan, who writes, “Salesforce remains poised to be one of the most strategic application software companies in the $1tn+ TAM cloud industry, in our view. With a broad and expanding platform that spans sales, service, ecommerce, marketing, BI/analytics, artificial intelligence, custom applications, integration, and collaboration, we view Salesforce as well positioned to capitalize on accelerated digital transformation spending…”

Rangan puts CRM shares on his firm’s Conviction List, with a Buy rating. His $315 price target implies room for 45% upside growth this year. (To watch Rangan’s track record, click here)

A tech company with the size and reach of Salesforce will always attract Wall Street’s attention – and CRM shares have 24 recent reviews on file. Of these, 19 are to Buy with only 5 to Hold, making the analyst consensus rating a Strong Buy. The average price target of $277.30 suggests a 28% upside potential from the trading price of $216.80. (See CRM stock analysis on TipRanks)

Jamf Holding (JAMF)

High-tech products – laptops, tablets, smartphones, and their accessories – have revolutionized the ways that we interact with each other, with our colleagues and customers, with our electronic devices. Jamf Holdings, a Wisconsin-based software company, specializes in producing IT administration products for Apple devices running macOS, iOS, iPadOS, and tvOS. Jamf’s products allow system administrators to manage groups of devices, create polices, restrict device features, and even activate remote features such as setup, lock, and wipe.

Apple has been one of the market’s great growth stories in the past decade, and Jamf offers investors a way to piggyback on the tech giant. Jamf held its IPO in July of last year, and the shares quickly showed large gains. The 18 million shares put on the market started at $26 and gained 51% in their first day of trading.

The company has also reported steadily increasing revenues since its IPO. 2Q20, the first quarter reported after the opening, showed $62 million at the top line; Q3 and Q4 showed $70.4 million and $76.4 million respectively. Earnings, as in many tech firms, show a net loss.

In his coverage of JAMF for Goldman Sachs, analyst Rod Hall sees the company with a clear path forward.

“We believe Jamf’s unique remote management solutions for Apple products should continue to benefit the company as remote working and study trends seem like they are here to stay… Jamf noted that its outperformance in Q4 was driven by a broad-based demand with >25% Y/Y growth across every product, geography and major industries,” Hall noted.

Hall puts a Buy rating on Jamf’s stock, along with a $52 price target that indicates a 40% upside potential for the shares. (To watch Hall’s track record, click here)

The Strong Buy analyst consensus rating on JAMF is unanimous, based on 6 recent Buy-side reviews. The shares are priced at $37.01 and their $47 average price target suggests a ~27% upside for the next 12 months. (See JAMF stock analysis on TipRanks)

To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

The post Goldman Sachs: These 3 Stocks Could Spike at Least 40% appeared first on TipRanks Financial Blog.

Read More

Continue Reading

International

Copper Soars, Iron Ore Tumbles As Goldman Says “Copper’s Time Is Now”

Copper Soars, Iron Ore Tumbles As Goldman Says "Copper’s Time Is Now"

After languishing for the past two years in a tight range despite recurring…

Published

on

Copper Soars, Iron Ore Tumbles As Goldman Says "Copper's Time Is Now"

After languishing for the past two years in a tight range despite recurring speculation about declining global supply, copper has finally broken out, surging to the highest price in the past year, just shy of $9,000 a ton as supply cuts hit the market; At the same time the price of the world's "other" most important mined commodity has diverged, as iron ore has tumbled amid growing demand headwinds out of China's comatose housing sector where not even ghost cities are being built any more.

Copper surged almost 5% this week, ending a months-long spell of inertia, as investors focused on risks to supply at various global mines and smelters. As Bloomberg adds, traders also warmed to the idea that the worst of a global downturn is in the past, particularly for metals like copper that are increasingly used in electric vehicles and renewables.

Yet the commodity crash of recent years is hardly over, as signs of the headwinds in traditional industrial sectors are still all too obvious in the iron ore market, where futures fell below $100 a ton for the first time in seven months on Friday as investors bet that China’s years-long property crisis will run through 2024, keeping a lid on demand.

Indeed, while the mood surrounding copper has turned almost euphoric, sentiment on iron ore has soured since the conclusion of the latest National People’s Congress in Beijing, where the CCP set a 5% goal for economic growth, but offered few new measures that would boost infrastructure or other construction-intensive sectors.

As a result, the main steelmaking ingredient has shed more than 30% since early January as hopes of a meaningful revival in construction activity faded. Loss-making steel mills are buying less ore, and stockpiles are piling up at Chinese ports. The latest drop will embolden those who believe that the effects of President Xi Jinping’s property crackdown still have significant room to run, and that last year’s rally in iron ore may have been a false dawn.

Meanwhile, as Bloomberg notes, on Friday there were fresh signs that weakness in China’s industrial economy is hitting the copper market too, with stockpiles tracked by the Shanghai Futures Exchange surging to the highest level since the early days of the pandemic. The hope is that headwinds in traditional industrial areas will be offset by an ongoing surge in usage in electric vehicles and renewables.

And while industrial conditions in Europe and the US also look soft, there’s growing optimism about copper usage in India, where rising investment has helped fuel blowout growth rates of more than 8% — making it the fastest-growing major economy.

In any case, with the demand side of the equation still questionable, the main catalyst behind copper’s powerful rally is an unexpected tightening in global mine supplies, driven mainly by last year’s closure of a giant mine in Panama (discussed here), but there are also growing worries about output in Zambia, which is facing an El Niño-induced power crisis.

On Wednesday, copper prices jumped on huge volumes after smelters in China held a crisis meeting on how to cope with a sharp drop in processing fees following disruptions to supplies of mined ore. The group stopped short of coordinated production cuts, but pledged to re-arrange maintenance work, reduce runs and delay the startup of new projects. In the coming weeks investors will be watching Shanghai exchange inventories closely to gauge both the strength of demand and the extent of any capacity curtailments.

“The increase in SHFE stockpiles has been bigger than we’d anticipated, but we expect to see them coming down over the next few weeks,” Colin Hamilton, managing director for commodities research at BMO Capital Markets, said by phone. “If the pace of the inventory builds doesn’t start to slow, investors will start to question whether smelters are actually cutting and whether the impact of weak construction activity is starting to weigh more heavily on the market.”

* * *

Few have been as happy with the recent surge in copper prices as Goldman's commodity team, where copper has long been a preferred trade (even if it may have cost the former team head Jeff Currie his job due to his unbridled enthusiasm for copper in the past two years which saw many hedge fund clients suffer major losses).

As Goldman's Nicholas Snowdon writes in a note titled "Copper's time is now" (available to pro subscribers in the usual place)...

... there has been a "turn in the industrial cycle." Specifically according to the Goldman analyst, after a prolonged downturn, "incremental evidence now points to a bottoming out in the industrial cycle, with the global manufacturing PMI in expansion for the first time since September 2022." As a result, Goldman now expects copper to rise to $10,000/t by year-end and then $12,000/t by end of Q1-25.’

Here are the details:

Previous inflexions in global manufacturing cycles have been associated with subsequent sustained industrial metals upside, with copper and aluminium rising on average 25% and 9% over the next 12 months. Whilst seasonal surpluses have so far limited a tightening alignment at a micro level, we expect deficit inflexions to play out from quarter end, particularly for metals with severe supply binds. Supplemented by the influence of anticipated Fed easing ahead in a non-recessionary growth setting, another historically positive performance factor for metals, this should support further upside ahead with copper the headline act in this regard.

Goldman then turns to what it calls China's "green policy put":

Much of the recent focus on the “Two Sessions” event centred on the lack of significant broad stimulus, and in particular the limited property support. In our view it would be wrong – just as in 2022 and 2023 – to assume that this will result in weak onshore metals demand. Beijing’s emphasis on rapid growth in the metals intensive green economy, as an offset to property declines, continues to act as a policy put for green metals demand. After last year’s strong trends, evidence year-to-date is again supportive with aluminium and copper apparent demand rising 17% and 12% y/y respectively. Moreover, the potential for a ‘cash for clunkers’ initiative could provide meaningful right tail risk to that healthy demand base case. Yet there are also clear metal losers in this divergent policy setting, with ongoing pressure on property related steel demand generating recent sharp iron ore downside.

Meanwhile, Snowdon believes that the driver behind Goldman's long-running bullish view on copper - a global supply shock - continues:

Copper’s supply shock progresses. The metal with most significant upside potential is copper, in our view. The supply shock which began with aggressive concentrate destocking and then sharp mine supply downgrades last year, has now advanced to an increasing bind on metal production, as reflected in this week's China smelter supply rationing signal. With continued positive momentum in China's copper demand, a healthy refined import trend should generate a substantial ex-China refined deficit this year. With LME stocks having halved from Q4 peak, China’s imminent seasonal demand inflection should accelerate a path into extreme tightness by H2. Structural supply underinvestment, best reflected in peak mine supply we expect next year, implies that demand destruction will need to be the persistent solver on scarcity, an effect requiring substantially higher pricing than current, in our view. In this context, we maintain our view that the copper price will surge into next year (GSe 2025 $15,000/t average), expecting copper to rise to $10,000/t by year-end and then $12,000/t by end of Q1-25’

Another reason why Goldman is doubling down on its bullish copper outlook: gold.

The sharp rally in gold price since the beginning of March has ended the period of consolidation that had been present since late December. Whilst the initial catalyst for the break higher came from a (gold) supportive turn in US data and real rates, the move has been significantly amplified by short term systematic buying, which suggests less sticky upside. In this context, we expect gold to consolidate for now, with our economists near term view on rates and the dollar suggesting limited near-term catalysts for further upside momentum. Yet, a substantive retracement lower will also likely be limited by resilience in physical buying channels. Nonetheless, in the midterm we continue to hold a constructive view on gold underpinned by persistent strength in EM demand as well as eventual Fed easing, which should crucially reactivate the largely for now dormant ETF buying channel. In this context, we increase our average gold price forecast for 2024 from $2,090/toz to $2,180/toz, targeting a move to $2,300/toz by year-end.

Much more in the full Goldman note available to pro subs.

Tyler Durden Fri, 03/15/2024 - 14:25

Read More

Continue Reading

Government

Moderna turns the spotlight on long Covid with new initiatives

Moderna’s latest Covid effort addresses the often-overlooked chronic condition of long Covid — and encourages vaccination to reduce risks. A digital…

Published

on

Moderna’s latest Covid effort addresses the often-overlooked chronic condition of long Covid — and encourages vaccination to reduce risks. A digital campaign debuted Friday along with a co-sponsored event in Detroit offering free CT scans, which will also be used in ongoing long Covid research.

In a new video, a young woman describes her three-year battle with long Covid, which includes losing her job, coping with multiple debilitating symptoms and dealing with the negative effects on her family. She ends by saying, “The only way to prevent long Covid is to not get Covid” along with an on-screen message about where to find Covid-19 vaccines through the vaccines.gov website.

Kate Cronin

“Last season we saw people would get a flu shot, but they didn’t always get a Covid shot,” said Moderna’s Chief Brand Officer Kate Cronin. “People should get their flu shot, but they should also get their Covid shot. There’s no risk of long flu, but there is the risk of long-term effects of Covid.”

It’s Moderna’s “first effort to really sound the alarm,” she said, and the debut coincides with the second annual Long Covid Awareness Day.

An estimated 17.6 million Americans are living with long Covid, according to the latest CDC data. About four million of them are out of work because of the condition, resulting in an estimated $170 billion in lost wages.

While HHS anted up $45 million in grants last year to expand long Covid support initiatives along with public health campaigns, the condition is still often ignored and underfunded.

“It’s not just about the initial infection of Covid, but also if you get it multiple times, your risks goes up significantly,” Cronin said. “It’s important that people understand that.”

Read More

Continue Reading

Government

Consequences Minus Truth

Consequences Minus Truth

Authored by James Howard Kunstler via Kunstler.com,

“People crave trust in others, because God is found there.”

-…

Published

on

Consequences Minus Truth

Authored by James Howard Kunstler via Kunstler.com,

“People crave trust in others, because God is found there.”

- Dom de Bailleul

The rewards of civilization have come to seem rather trashy in these bleak days of late empire; so, why even bother pretending to be civilized? This appears to be the ethos driving our politics and culture now. But driving us where? Why, to a spectacular sort of crack-up, and at warp speed, compared to the more leisurely breakdown of past societies that arrived at a similar inflection point where Murphy’s Law replaced the rule of law.

The US Military Academy at West point decided to “upgrade” its mission statement this week by deleting the phrase Duty, Honor, Country that summarized its essential moral orientation. They replaced it with an oblique reference to “Army Values,” without spelling out what these values are, exactly, which could range from “embrace the suck” to “charlie foxtrot” to “FUBAR” — all neatly applicable to our country’s current state of perplexity and dread.

Are you feeling more confident that the US military can competently defend our country? Probably more like the opposite, because the manipulation of language is being used deliberately to turn our country inside-out and upside-down. At this point we probably could not successfully pacify a Caribbean island if we had to, and you’ve got to wonder what might happen if we have to contend with countless hostile subversive cadres who have slipped across the border with the estimated nine-million others ushered in by the government’s welcome wagon.

Momentous events await. This Monday, the Supreme Court will entertain oral arguments on the case Missouri, et al. v. Joseph R. Biden, Jr., et al. The integrity of the First Amendment hinges on the decision. Do we have freedom of speech as set forth in the Constitution? Or is it conditional on how government officials feel about some set of circumstances? At issue specifically is the government’s conduct in coercing social media companies to censor opinion in order to suppress so-called “vaccine hesitancy” and to manipulate public debate in the 2020 election. Government lawyers have argued that they were merely “communicating” with Twitter, Facebook, Google, and others about “public health disinformation and election conspiracies.”

You can reasonably suppose that this was our government’s effort to disable the truth, especially as it conflicted with its own policy and activities — from supporting BLM riots to enabling election fraud to mandating dubious vaccines. Former employees of the FBI and the CIA were directly implanted in social media companies to oversee the carrying-out of censorship orders from their old headquarters. The former general counsel (top lawyer) for the FBI, James Baker, slid unnoticed into the general counsel seat at Twitter until Elon Musk bought the company late in 2022 and flushed him out. The so-called Twitter Files uncovered by indy reporters Matt Taibbi, Michael Shellenberger, and others, produced reams of emails from FBI officials nagging Twitter execs to de-platform people and bury their dissent. You can be sure these were threats, not mere suggestions.

One of the plaintiffs joined to Missouri v. Biden is Dr. Martin Kulldorff, a biostatistician and professor at the Harvard Medical School, who opposed Covid-19 lockdowns and vaccine mandates. He was one of the authors of the open letter called The Great Barrington Declaration (October, 2020) that articulated informed medical dissent for a bamboozled public. He was fired from his job at Harvard just this past week for continuing his refusal to take the vaccine. Harvard remains among a handful of institutions that still require it, despite massive evidence that it is ineffective and hazardous. Like West Point, maybe Harvard should ditch its motto, Veritas, Latin for “truth.”

A society hostile to truth can’t possibly remain civilized, because it will also be hostile to reality. That appears to be the disposition of the people running things in the USA these days. The problem, of course, is that this is not a reality-optional world, despite the wishes of many Americans (and other peoples of Western Civ) who wish it would be.

Next up for us will be “Joe Biden’s” attempt to complete the bankruptcy of our country with $7.3-trillion proposed budget, 20 percent over the previous years spending, based on a $5-billion tax increase. Good luck making that work. New York City alone is faced with paying $387 a day for food and shelter for each of an estimated 64,800 illegal immigrants, which amounts to $9.15-billion a year. The money doesn’t exist, of course. New York can thank “Joe Biden’s” executive agencies for sticking them with this unbearable burden. It will be the end of New York City. There will be no money left for public services or cultural institutions. That’s the reality and that’s the truth.

A financial crack-up is probably the only thing short of all-out war that will get the public’s attention at this point. I wouldn’t be at all surprised if it happened next week. Historians of the future, stir-frying crickets and fiddleheads over their campfires will marvel at America’s terminal act of gluttony: managing to eat itself alive.

*  *  *

Support his blog by visiting Jim’s Patreon Page or Substack

Tyler Durden Fri, 03/15/2024 - 14:05

Read More

Continue Reading

Trending